- Investing Ideas
- South Korean Pharmaceuticals & Biotech Sustainable Track Record
South Korean Pharmaceuticals & Biotech Sustainable Track Record
Results
5
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
5 companies
PharmaResearch
Market Cap: ₩3.6t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩348,500.00
7D
3.6%
1Y
27.9%
JW Lifescience
Market Cap: ₩207.6b
Provides national infusion solutions in South Korea and internationally.
A234080
₩13,410.00
7D
3.6%
1Y
28.9%
SK Biopharmaceuticals
Market Cap: ₩8.9t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩113,400.00
7D
1.7%
1Y
-9.6%
Samsung BiologicsLtd
Market Cap: ₩79.6t
Together with its subsidiaries engages in the manufacturing of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,719,000.00
7D
1.1%
1Y
-5.2%
DreamCIS
Market Cap: ₩147.5b
Operates as a clinical research organization in South Korea.
A223250
₩6,000.00
7D
-0.8%
1Y
89.3%